MiR-34a deficiency enhances nucleic acid sensing and type I IFN signaling in a mouse model of Alzheimer's disease
Junling Yang, George E. Tsourdinis, Charlotte Holas, Mark Maienschein‐Cline, Robert Lalonde, Ken-ichiro Fukuchi
This study shows that miR-34a deficiency in Alzheimer's disease mice increases type I IFN signaling and microglial activation, linked to improved memory and altered amyloid-beta ratios.
Frontiers in Immunology · Feb 24, 2026Peer-reviewedNeuroscience